Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors

Clinical trial NCT03935334 · COMPLETED

Trial details

NCT number: NCT03935334
Sponsor: AryoGen Pharmed Co.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hemophilia A or B With Inhibitor

Start date: 2018-07-23
Primary completion: 2021-01-31
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.